SRI’s state-of-the-art 40,000-square-foot research facility is located in Harrisonburg, Virginia on a 25-acre campus in the Innovation Village at Rockingham. The facility provides a convenient base for collaboration with academic institutions in Virginia and the greater Washington, D.C. area.
SRI moved into its new Shenandoah Valley laboratory facility in 2009. At the highest level, SRI SV focuses on improving the health and well being of people throughout the world. As part of SRI Biosciences, research at SRI SV complements research and development (R&D) capabilities at other SRI locations, including SRI's Menlo Park, California headquarters.
R&D at the Virginia facility focuses on several program areas, including:
- Research, discovery, and development: Health sciences; discovery sciences; pharmaceutical sciences; preclinical development; clinical translation
- Personalized medicine: Companion diagnostics; precision biologics, drugs, and vaccines; biomarkers
An example of the activities at SRI SV is a program examining the proteomics of host-vector-pathogen interactions targeting bacteria, parasites, and viruses to provide solutions to health care scourges such as AIDS, dengue fever, hepatitis, methicillin-resistant staphylococcus aureus (MRSA), tuberculosis, and West Nile virus.
SRI SV has expanded to include agricultural and related applications. One example is the SRI spin-off company, Redcoat Solutions, a new company focused on developing products to detect and treat insect infestations. Over time, SRI SV plans to add high-technology programs in other areas, such as security and defense, microscience, energy, and computing technology. As SRI SV conducts cutting-edge research on globally important problems, it is expected to serve as a magnet for student intern training, and for faculty to spend their sabbaticals actively engaged in R&D with real-world applications. SRI's collaborations with leading Virginia academic institutions are facilitated by government funding, sponsored industrial research, and private foundation support.
SRI SV was established in 2006 as the SRI Center for Advanced Drug Research (CADRE) to foster economic development centered on research and technology. The new facility received support from the Commonwealth of Virginia and partnerships with James Madison University, Rockingham County, the City of Harrisonburg, the Virginia Economic Development Partnership, and the Shenandoah Valley Partnership. Stakeholders include the education sector, business and industry, economic development advocates, workforce development groups, community organizations, and local government.
Watch video of the facility's dedication in 2009.
In 2011, SRI announced plans to expand the Shenandoah Valley facility, with expansion underway again in 2013.
